FDEV - ETF AI Analysis
Top Page
Fidelity International Multifactor ETF (FDEV)
Rating:66Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Well-Performing Top Holdings
Several of the largest positions, especially in gold and other selected stocks, have delivered strong year-to-date results that support the fund’s overall performance.
Low Expense Ratio
The fund’s relatively low fee means more of the investment returns stay in investors’ pockets over time.
Negative Factors
Heavy Exposure to Financials and Materials
A large share of the portfolio is in financial and materials stocks, which can make the fund more sensitive to downturns in these sectors.
Limited Technology and Health Care Weight
The ETF has relatively small allocations to technology and health care, so investors may miss out if those growth areas outperform the broader market.
Concentration in a Few Countries
Significant weights in Japan and the UK mean the fund’s returns can be heavily influenced by economic and market conditions in those specific markets.
FDEV vs. SPDR S&P 500 ETF (SPY)
AUM271.88M
RegionDeveloped Markets
Expense Ratio0.18%
Beta0.54
IssuerFidelity
Inception DateFeb 26, 2019
Dividend Yield2.75%
Asset ClassEquity
Index TrackedFidelity International Multifactor Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume24,915
30 Day Avg. Volume37,163
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
39.55Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering198
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FDEV Summary
Fidelity International Multifactor ETF (FDEV) tracks the Fidelity International Multifactor Index, which picks stocks from many countries outside the U.S. using a rules-based approach. It owns companies across sectors like financials, materials, and utilities, including names such as Kinross Gold and Engie. Someone might invest in FDEV to get broad international diversification in a single fund, with exposure to many regions like Japan, the UK, and Canada. A key risk is that international stock prices can go up and down with global markets and currency swings, so the value of this ETF can be volatile.
How much will it cost me?The Fidelity International Multifactor ETF (Ticker: FDEV) has an expense ratio of 0.19%, which means you’ll pay $1.90 per year for every $1,000 invested. This is lower than average for ETFs because it is passively managed, tracking a specific index rather than relying on active stock selection.
What would affect this ETF?FDEV's focus on developed markets outside the U.S. and its exposure to sectors like financials, materials, and utilities could benefit from global economic growth, infrastructure spending, and stable demand for essential services. However, challenges such as rising interest rates, regulatory changes in international markets, or economic slowdowns in key regions could negatively impact its performance. Additionally, sector-specific risks, like fluctuating commodity prices for materials or energy, may influence returns.
FDEV Top 10 Holdings
FDEV is leaning heavily on international energy and health care giants, with Canadian Natural and Suncor quietly powering the fund thanks to their rising share prices and solid fundamentals. Shell is also adding some steady fuel to returns, even if its momentum has cooled a bit. On the health care side, AstraZeneca and Novartis are more mixed, while Roche has been lagging and acting as a small brake on performance. With a developed-markets, ex-U.S. focus and no single stock dominating, the story here is diversified global exposure with an energy tilt.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Shell (UK) | 1.88% | $5.11M | £191.74B | 48.20% | 73 Outperform | |
| AstraZeneca | 1.68% | $4.56M | $316.55B | 52.18% | 80 Outperform | |
| Engie SA | 1.46% | $3.97M | €73.66B | 61.55% | 64 Neutral | |
| Novartis AG | 1.43% | $3.88M | CHF222.29B | 41.43% | 80 Outperform | |
| Endesa SA | 1.40% | $3.80M | €40.14B | 59.45% | 63 Neutral | |
| Roche Holding AG | 1.38% | $3.75M | $318.75B | 31.82% | 73 Outperform | |
| Canadian Natural | 1.26% | $3.44M | C$133.84B | 70.53% | 81 Outperform | |
| Centrica | 1.25% | $3.40M | £9.57B | 48.25% | 66 Neutral | |
| ― | 1.25% | $3.40M | ― | ― | ― | |
| Suncor Energy | 1.21% | $3.28M | $76.44B | 92.62% | 77 Outperform |
FDEV Technical Analysis
Positive
―
Price Trends
36.20
Positive
35.22
Positive
33.74
Positive
Market Momentum
0.19
Negative
61.06
Neutral
83.27
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FDEV, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.59, equal to the 50-day MA of 36.20, and equal to the 200-day MA of 33.74, indicating a bullish trend. The MACD of 0.19 indicates Negative momentum. The RSI at 61.06 is Neutral, neither overbought nor oversold. The STOCH value of 83.27 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FDEV.
FDEV Peer Comparison
Comparison Results
Performance Comparison
FDEV
Fidelity International Multifactor ETF
36.78
8.38
29.51%
SEIE
SEI Select International Equity ETF
―
―
―
IMFL
Invesco International Developed Dynamic Multifactor ETF
―
―
―
IDHQ
Invesco S&P International Developed High Quality ETF
―
―
―
TLTD
FlexShares Morningstar Developed Markets ex-US Factor Tilt
―
―
―
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents